Redmile Group, LLC - Insider Non-Derivative Transactions at FATE THERAPEUTICS INC (FATE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 26, 2023, Redmile Group, LLC's relationship to FATE THERAPEUTICS INC (FATE) is Director,TenPercentOwner, and currently has 13,180,388 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FATE insiders.
Data Source: SEC.
Redmile Group, LLC - Insider Non-Derivative Transactions of FATE Common Stock
Redmile Group, LLC - Insider Non-Derivative Transactions at FATE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 27, 2023 | J -- (Common Stock) | 1655370 | 3.72 | 13135758 |
| Dec 27, 2023 | P -- (Common Stock) | 44630 | 3.72 | 13180388 |
| Apr 15, 2023 | J -- (Common Stock) | 5492385 | 5.84 | 12833419 |
| Apr 15, 2023 | Sell -- (Common Stock) | 302339 | 5.84 | 12833419 |
| Apr 15, 2023 | P -- (Common Stock) | 25700 | 6 | 12859119 |
| Apr 14, 2023 | C -- (Common Stock) | 167205 | 0 | 13135758 |